AU5587594A - New substituted azetidinones as anti-inflammatory and antidegenerative agents - Google Patents
New substituted azetidinones as anti-inflammatory and antidegenerative agentsInfo
- Publication number
- AU5587594A AU5587594A AU55875/94A AU5587594A AU5587594A AU 5587594 A AU5587594 A AU 5587594A AU 55875/94 A AU55875/94 A AU 55875/94A AU 5587594 A AU5587594 A AU 5587594A AU 5587594 A AU5587594 A AU 5587594A
- Authority
- AU
- Australia
- Prior art keywords
- inflammatory
- new substituted
- substituted azetidinones
- antidegenerative agents
- antidegenerative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96679992A | 1992-10-27 | 1992-10-27 | |
| US966799 | 1992-10-27 | ||
| US99219392A | 1992-12-17 | 1992-12-17 | |
| US992193 | 1992-12-17 | ||
| PCT/US1993/010269 WO1994010143A1 (en) | 1992-10-27 | 1993-10-26 | New substituted azetidinones as anti-inflammatory and antidegenerative agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5587594A true AU5587594A (en) | 1994-05-24 |
Family
ID=27130492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU55875/94A Abandoned AU5587594A (en) | 1992-10-27 | 1993-10-26 | New substituted azetidinones as anti-inflammatory and antidegenerative agents |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5952321A (2) |
| EP (1) | EP0666846A1 (2) |
| JP (1) | JPH08502752A (2) |
| AU (1) | AU5587594A (2) |
| CA (1) | CA2147129A1 (2) |
| WO (1) | WO1994010143A1 (2) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU677986B2 (en) * | 1993-04-23 | 1997-05-15 | Bristol-Myers Squibb Company | N-substituted 2-azetidinones |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69734321T2 (de) * | 1996-02-23 | 2006-08-10 | Eli Lilly And Co., Indianapolis | Non-peptidische vasopressin via antagonisten |
| WO1999004826A1 (en) * | 1997-07-24 | 1999-02-04 | The Australian National University | Method for detection of fibrin clots |
| WO2000005204A1 (en) * | 1998-07-23 | 2000-02-03 | Shionogi & Co., Ltd. | MONOCYCLIC β-LACTAM COMPOUNDS AND CHYMASE INHIBITORS CONTAINING THE SAME |
| US6982251B2 (en) * | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| PT1355644E (pt) | 2001-01-26 | 2006-11-30 | Schering Corp | Utilização de compostos azetidinona substituídos para o tratamento de sitosterolemia |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| RS20100015A (sr) | 2001-01-26 | 2010-12-31 | Schering Corporation | Kombinacija aktivatora receptora aktiviranog peroksizom- proliferatorom (ppar) fenofibrata sa inhibitorom apsorpcije sterola ezetimibom za vaskularne indikacije |
| EP1429756B1 (en) | 2001-09-21 | 2006-11-22 | Schering Corporation | Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| JP2006508188A (ja) | 2002-11-06 | 2006-03-09 | シェーリング コーポレイション | 脱髄の処置のためのコレステロール吸収インヒビター |
| CN1756756A (zh) | 2003-03-07 | 2006-04-05 | 先灵公司 | 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途 |
| DE602004016123D1 (de) | 2003-03-07 | 2008-10-09 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
| CN1756755A (zh) * | 2003-03-07 | 2006-04-05 | 先灵公司 | 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途 |
| US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| DE10336185A1 (de) * | 2003-08-07 | 2005-02-24 | Bayer Chemicals Ag | Enantiomerenangereicherte 1-Phenylethylamine |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1192952A (en) * | 1967-03-31 | 1970-05-28 | Lepetit Spa | Azetidine-2-One Derivatives |
| DE1906401A1 (de) * | 1969-02-08 | 1970-08-27 | Hoechst Ag | Verfahren zur Herstellung von 4-Acyloxy-azetidin-2-onen |
| BE755940A (fr) * | 1969-09-09 | 1971-03-09 | Hoechst Ag | Azetidinones-2 portant des substituants en position 4 et leur preparation |
| DE2046823A1 (de) * | 1970-09-23 | 1972-03-30 | Farbwerke Hoechst AG vormals Meister Lucius & Brüning, 6000 Frankfurt | Neue Azetidinone-(2) und Verfahren zu deren Herstellung |
| DE2046822A1 (de) * | 1970-09-23 | 1972-03-30 | Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt | Neue Azetidinone-(2) und Verfahren zu deren Herstellung |
| US4064120A (en) * | 1976-11-01 | 1977-12-20 | E. R. Squibb & Sons, Inc. | 3,3-Dichloro-2-azetidinone derivatives having antiinflammatory activity |
| US4166907A (en) * | 1976-11-01 | 1979-09-04 | E. R. Squibb & Sons, Inc. | 3,3-Dichloro-2-azetidinone derivatives having antiinflammatory activity |
| LU77306A1 (2) * | 1977-05-09 | 1979-01-18 | ||
| US4115382A (en) * | 1977-06-06 | 1978-09-19 | E. R. Squibb & Sons, Inc. | 3,3-Dichloro-2-azetidinone derivatives having basic substituents |
| FR2404632A1 (fr) * | 1977-09-30 | 1979-04-27 | Kyowa Hakko Kogyo Kk | Nouveaux derives de l'azetidinone et leurs procedures de fabrication |
| EP0003960B1 (de) * | 1978-02-02 | 1983-06-29 | Ciba-Geigy Ag | 6-Substituierte Thia-Azaverbindungen, ihre Herstellung und diese enthaltende pharmazeutische Präparate |
| US4174317A (en) * | 1978-03-24 | 1979-11-13 | E. R. Squibb & Sons, Inc. | 3,3-Dichloro-2-azetidinone derivatives |
| AT365594B (de) * | 1978-11-24 | 1982-01-25 | Erba Farmitalia | Verfahren zur herstellung von neuen 7-oxo-4-thia1-aza-bicyclo-(3,2,0)heptanderivaten |
| DE3068790D1 (en) * | 1979-06-28 | 1984-09-06 | Sumitomo Chemical Co | De-arylmethylation of n-mono- or n-diarylmethyl-beta-lactams; novel azetizinones having anti-bacterial activity |
| US4260743A (en) * | 1979-12-31 | 1981-04-07 | Gist-Brocades N.V. | Preparation of β-lactams and intermediates therefor |
| DE3007298A1 (de) * | 1980-02-27 | 1981-09-03 | Merck Patent Gmbh, 6100 Darmstadt | Verfahren zur herstellung von azetidinonen und deren verwendung |
| HU181742B (en) * | 1980-09-15 | 1983-11-28 | Richter Gedeon Vegyeszet | Process for producing new azetidinone derivatives |
| EP0051813B1 (en) * | 1980-11-06 | 1986-07-30 | Hoechst Uk Limited | 7-oxo-4-thia-1-aza(3,2,0)heptane and 7-oxo-4-thia-1-aza(3,2,0)hept-2-ene derivatives |
| JPS5857360A (ja) * | 1981-10-01 | 1983-04-05 | Ajinomoto Co Inc | アゼチジノン誘導体 |
| US4534896A (en) * | 1983-06-13 | 1985-08-13 | E. R. Squibb & Sons, Inc. | 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid) |
| US4576749A (en) * | 1983-10-03 | 1986-03-18 | E. R. Squibb & Sons, Inc. | 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones |
| US4559335A (en) * | 1983-10-03 | 1985-12-17 | E. R. Squibb & Sons, Inc. | 3-Acylamino-1-carboxymethyloxy (or thio) carbonyl-2-azetidinones |
| US4680391A (en) * | 1983-12-01 | 1987-07-14 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US5229381A (en) * | 1983-12-01 | 1993-07-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| ATE133954T1 (de) * | 1986-11-12 | 1996-02-15 | Merck & Co Inc | Substituierte cephalosporinsulfone als anti- entzündliche und anti-degenerative mittel |
| IL89835A0 (en) * | 1988-04-11 | 1989-12-15 | Merck & Co Inc | Substituted azetidinones,their preparation and pharmaceutical compositions containing them |
| IL99658A0 (en) * | 1990-10-15 | 1992-08-18 | Merck & Co Inc | Substituted azetidinones and pharmaceutical compositions containing them |
| US5104862A (en) * | 1991-03-20 | 1992-04-14 | Merck & Co., Inc. | Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
| WO1993000332A1 (en) * | 1991-06-25 | 1993-01-07 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US5348953A (en) * | 1991-06-25 | 1994-09-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
-
1993
- 1993-10-26 JP JP6511259A patent/JPH08502752A/ja active Pending
- 1993-10-26 WO PCT/US1993/010269 patent/WO1994010143A1/en not_active Ceased
- 1993-10-26 AU AU55875/94A patent/AU5587594A/en not_active Abandoned
- 1993-10-26 EP EP94901205A patent/EP0666846A1/en not_active Withdrawn
- 1993-10-26 CA CA002147129A patent/CA2147129A1/en not_active Abandoned
-
1996
- 1996-12-12 US US08/764,775 patent/US5952321A/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU677986B2 (en) * | 1993-04-23 | 1997-05-15 | Bristol-Myers Squibb Company | N-substituted 2-azetidinones |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2147129A1 (en) | 1994-05-11 |
| WO1994010143A1 (en) | 1994-05-11 |
| JPH08502752A (ja) | 1996-03-26 |
| EP0666846A1 (en) | 1995-08-16 |
| EP0666846A4 (2) | 1995-09-20 |
| US5952321A (en) | 1999-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU8583391A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| AU1858392A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| AU4165993A (en) | Aminediol compounds and derivatives and halohydrin intermediates | |
| AU4211193A (en) | New carbohydrate-based anti-inflammatory agents | |
| AU4166393A (en) | Auto-reclosers | |
| AU3561193A (en) | TNF-muteins | |
| AU3991693A (en) | Pyrazinoindoles | |
| AU4669293A (en) | Cholesterol-lowering agents | |
| AU3042892A (en) | Rockbolt | |
| AU4829793A (en) | Quinazoline derivatives | |
| AU4177593A (en) | Benzophenonehydrazones | |
| AU3551993A (en) | Tetraazacyclododecane derivative and its use | |
| AU685767B2 (en) | Substituted benzazepinones | |
| FI951992A7 (fi) | Uusia substituoituja atsetidinoneja anti-inflammatorisina ja antidegeneratiivisina aineina | |
| AU7080094A (en) | Substituted azetidinone amide derivatives as anti-inflammatory and antidegenerative agents | |
| AU5802894A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| AU4156393A (en) | Heterocyclyltriazolinones | |
| AU3562193A (en) | Morpholin- and thiomorpholin-4-ylamides | |
| AU4164793A (en) | Heterocyclyltriazolinones | |
| AU5371694A (en) | Use of the tarchonanthus camphoratus | |
| EP0505095A3 (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| EP0505097A3 (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| AU4864693A (en) | Alkoxymethyl-substituted pyridonebiphenyls | |
| AU3185693A (en) | Pyrrolylbenzodiazepinones | |
| AU4425593A (en) | New isobutyl-substituted methanesulphonyl-quinolylmethoxyphenyl-cycloalkylacetamides |